Myanmar Health Sciences Research Journal
Next Prev
Aims of MHSR Journal
  • To serve as an important medium for the publication of original research in the field of medical science and health research, thus filling gaps in health knowledge for effective utilization of research findings
  • To impart current medical knowledge and updated scientific information obtained from research to health professionals for better and appropriate health care management
  • To disseminate recent basic, applied and social research findings among health personnel of different strata for enhancing worldwide health development


Archives   2007

Myanmar   Health   Sciences   Research   Journal

Volume   19,  Number   3

TITLE:   Detection of low level viral genome (HBV DNA) by Polymerase Chain Reaction in nonresponders of plasma-derived hepatitis B vaccine produced at the Department of Medical Research (Lower Myanmar).
AUTHOR:   Moh Moh Htun; Khin Pyone Kyi; Khin May Oo; San San Oo; Khin May Oo; Ohnmar Lwin; Kenji Abe
SOURCE:   Myanmar Health Sciences Research Journal. 2007; 19(3): 125-130
ABSTRACT:   Myanmar is an area of high endemicity for hepatitis B with a 35-60% infection rate and 10-15% HBsAg carrier rate. Several vaccine trials carried out at the Department of Medical Research (Lower Myanmar) using plasma- derived hepatitis B vaccine have shown that there was approximately 10% non-responder rate. Out of 337 apparently healthy persons who were initially screened for HBsAg, antiHBs and antiHBc by using the Abbott ELISA test kits (USA), 137 persons were negative for all markers (HBsAg, AntiHBs and AntiHBc). They were immunized with three doses of locally produced plasma-derived hepatitis B vaccine (10μg/ml) by intramuscular route in the deltoid region. One month after the completion of three doses of hepatitis B vaccine, 38 subjects who did not respond were vaccinated again using the same dose, site and route. Out of 38 vaccinees, 23 subjects did not have detectable levels (10 m IU/L) at two months after the booster vaccination. HBV DNA was extracted from all serum samples of nonresponders by using the phenol, chloroform and ethanol method. These extracted samples were tested for HBV DNA by using the Polymerase Chain Reaction (PCR). After the amplification of 40 cycles, HBV DNA was detected by 2% agarose gel electrophoresis. The short nucleotide of the HBV DNA (< 200bp) of the positive two samples were amplified successfully by nested PCR and sequenced by Taq Dye Deoxy TM Terminator Cycle Sequencing Kit. These two nonresponders (8.69%) may be due to silent HBV infection.
SUBJECT HEADINGS:   Genomics. Polymerase Chain Reaction. Hepatitis B Vaccines.
FULL TEXT:  

Back to Articles

Vision : Achieving a healthier nation through application of research findings          Mission Statement : To Develop and promote solutions to the major health problems of Myanmar